MOH — authorised 28 February 2011
- Marketing authorisation holder: ASTRAZENECA PHARMS
- Status: likely_approved
🇮🇱 Daliresp in Israel
MOH authorised Daliresp on 28 February 2011
Marketing authorisation
Daliresp in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in Israel
Frequently asked questions
Is Daliresp approved in Israel?
Yes. MOH authorised it on 28 February 2011.
Who is the marketing authorisation holder for Daliresp in Israel?
ASTRAZENECA PHARMS holds the Israeli marketing authorisation.